Delivery Order SPE2DB20D1100-SPE2DB25FE0VY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a $5.54K delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price, non-competitive delivery order with performance completion targeted for July 14, 2025, and fulfillment from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive award, with no set-aside designation, carries a ceiling value of $1,385.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 25, 2025. The award supports the federal government's pharmaceutical procurement needs through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive, non-set-aside award carries a ceiling value of $4,156.56 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,385.52 on June 18, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,313.12 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of ORGOVYX 120 mg tablets (30-count unit dose) with an ultimate completion date of October 16, 2025. The contract is non-competitive with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) with a ceiling value of $4,156.56 under a firm fixed-price contract. This non-competitive delivery order, issued on June 2, 2025, represents a single pharmaceutical procurement to be fulfilled by June 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,542.08 and an ultimate completion date of July 17, 2025. The contract was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ORGOVYX is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04 and completion targeted for April 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the awardee's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0VYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30-count units, with a contract ceiling value of $1,385.52 and a completion date of October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, with a primary IDC valued at $999,999,999.00 running through December 2026. This contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The current delivery order for ORGOVYX, a specialized pharmaceutical product, represents a small-value transaction consistent with AmerisourceBergen's extensive portfolio of federal medical supply deliveries across multiple therapeutic domains in support of the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/23/25 |